EPO and diabetic kidney disease: Figure 1 is a Forest plot representation of the significantly associated genetic variants with diabetic nephropathy- VEGFA, CCR5 (Chemokine Receptor 5), CCL2 (Chemokine ligand 2), IL-1 (Interleukin-1), MMP9 (Matrix Metallopeptidase 9), EPO (Erythropoietin), IL-8 (Interleukin-8), ADIPOQ (Adiponectin, C1Q And Collagen Domain Containing) and IL-10 (Interleukin-1).